Shree Ganesh Biotech India Ltd 15 May 2026 12:00 AM
Shree Ganesh Biotech India reports standalone net loss of Rs 0.15 crore in the March 2026 quarter,
Net Loss of Shree Ganesh Biotech India reported to Rs 0.15 crore in the quarter ended March 2026 as against net loss of Rs 0.95 crore during the previous quarter ended March 2025. Sales declined 29.57% to Rs 2.12 crore in the quarter ended March 2026 as against Rs 3.01 crore during the previous quarter ended March 2025.For the full year,net profit rose 35.71% to Rs 0.38 crore in the year ended March 2026 as against Rs 0.28 crore during the previous year ended March 2025. Sales declined 78.35% to Rs 4.97 crore in the year ended March 2026 as against Rs 22.96 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales2.123.01 -30 4.9722.96 -78 OPM %-20.28-47.18 --19.11-4.57 - PBDT-0.15-0.95 84 0.520.39 33 PBT-0.15-0.95 84 0.520.39 33 NP-0.15-0.95 84 0.380.28 36 Powered by Capital Market - Live News
Shree Ganesh Biotech India Ltd 05 May 2026 12:00 AM
Shree Ganesh Biotech India to hold board meeting,
Shree Ganesh Biotech India will hold a meeting of the Board of Directors of the Company on 14 May 2026.
Shree Ganesh Biotech India Ltd 29 Jan 2026 12:00 AM
Shree Ganesh Biotech India standalone net profit declines 58.44% in the December 2025 quarter,
Net profit of Shree Ganesh Biotech India declined 58.44% to Rs 0.32 crore in the quarter ended December 2025 as against Rs 0.77 crore during the previous quarter ended December 2024. Sales declined 95.14% to Rs 0.70 crore in the quarter ended December 2025 as against Rs 14.41 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales0.7014.41 -95 OPM %-7.143.26 - PBDT0.320.77 -58 PBT0.320.77 -58 NP0.320.77 -58 Powered by Capital Market - Live News
Shree Ganesh Biotech India Ltd 20 Jan 2026 12:00 AM
Shree Ganesh Biotech India to convene board meeting,
Shree Ganesh Biotech India will hold a meeting of the Board of Directors of the Company on 29 January 2026.Powered by Capital Market - Live News
Shree Ganesh Biotech India Ltd 08 Nov 2025 12:00 AM
Shree Ganesh Biotech India standalone net profit declines 96.88% in the September 2025 quarter,
Net profit of Shree Ganesh Biotech India declined 96.88% to Rs 0.01 crore in the quarter ended September 2025 as against Rs 0.32 crore during the previous quarter ended September 2024. Sales declined 61.11% to Rs 0.77 crore in the quarter ended September 2025 as against Rs 1.98 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales0.771.98 -61 OPM %-51.951.01 - PBDT0.010.32 -97 PBT0.010.32 -97 NP0.010.32 -97 Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now